Plakophilin-2

Plakophilin-2 (PKP2) is a protein that in humans is encoded by the PKP2 gene. It is a crucial component of the desmosome complex, a structure essential for cell adhesion and the integrity of the epithelium. Plakophilin-2 plays a significant role in the structural organization and function of the heart and skin tissues. Mutations in the PKP2 gene are associated with various cardiomyopathies, particularly arrhythmogenic right ventricular cardiomyopathy (ARVC), a condition characterized by the replacement of heart muscle with fatty and fibrous tissue, leading to heart rhythm problems.

Function

Plakophilin-2 is involved in linking cadherins to intermediate filaments in the cell. It is a part of the armadillo family of proteins and participates in the regulation of desmosomal and adherens junctions, which are critical for the mechanical coupling and signal transduction between cells, especially in the heart and skin. By maintaining the structural integrity of these tissues, PKP2 plays a vital role in their proper function.

Genetic Association with Disease

Mutations in the PKP2 gene are the most common genetic cause of arrhythmogenic right ventricular cardiomyopathy (ARVC). ARVC is a form of heart disease that primarily affects the right ventricle, leading to arrhythmias and heart failure. The disease mechanism involves the progressive loss of myocardial cells and their replacement with fibro-fatty tissue. This pathological change is believed to be triggered by defective cell adhesion, which is a direct consequence of dysfunctional plakophilin-2. Besides ARVC, mutations in PKP2 have also been implicated in other forms of cardiomyopathy, highlighting the importance of this protein in cardiac health.

Clinical Significance

The identification of PKP2 mutations in patients suspected of having ARVC is crucial for diagnosis, risk assessment, and management of the disease. Genetic testing for PKP2 mutations can help in identifying at-risk family members and in making decisions regarding lifestyle and potential treatments to mitigate the risk of arrhythmias and heart failure. Furthermore, understanding the molecular mechanisms by which PKP2 mutations lead to cardiomyopathy can aid in the development of targeted therapies.

Research Directions

Current research on plakophilin-2 includes studies aimed at elucidating its precise role in cell adhesion and signaling, the development of animal models to study the pathogenesis of ARVC and other cardiomyopathies linked to PKP2 mutations, and the exploration of potential therapeutic strategies to correct or compensate for the defective protein function in affected individuals.

See Also

• Desmosome
• Cardiomyopathy
• Arrhythmogenic right ventricular cardiomyopathy
• Cadherin
• Adherens junction

‎